New Immunotherapy Drug Could Triple Survival Rates, Replace Surgery for Bowel Cancer

Jun 2, 2024, 06:31 PM

A new immunotherapy drug that 'melts away' tumors could revolutionize the treatment of bowel cancer, potentially replacing surgery. Doctors have hailed the drug as a 'gamechanger,' with a key trial showing it to be more than ten times as effective as conventional treatments. The drug, already available on the NHS, could save hundreds of lives annually in the UK by tripling survival rates for a deadly type of bowel cancer. The promising results from the trial suggest that the drug could significantly improve patient outcomes and reduce the need for invasive surgical procedures.